中国民康医学
中國民康醫學
중국민강의학
MEDICAL JOURNAL OF CHINSEE PEOPLE HEALTH
2014年
15期
4-5,8
,共3页
艾司西酞普兰%西酞普兰%广泛性焦虑障碍
艾司西酞普蘭%西酞普蘭%廣汎性焦慮障礙
애사서태보란%서태보란%엄범성초필장애
Escitalopram%Citalopram%Generalized anxiety disorder
目的:探究艾司西酞普兰与西酞普兰治疗广泛性焦虑障碍的临床效果,为今后的临床工作提供参考依据。方法:选取广泛性焦虑障碍患者120例,按照治疗方法的不同分为对照组与观察组,对照组患者给予西酞普兰治疗,观察组患者给予艾司西酞普兰治疗,观察两组患者治疗后的临床效果及不良反应。结果:治疗第2、4、6周末,两组患者 HAMA 比较差异显著(P<0.01);治疗6周末,艾司西酞普兰组的总有效率为91.7%,西酞普兰组的总有效率为80.0%,比较差异有统计学意义(P<0.05)。艾司西酞普兰组患者的不良反应明显低于西酞普兰组(P<0.05),差异有统计学意义。结论:艾司西酞普兰治疗广泛性焦虑障碍临床效果良好,不良反应少,值得临床推广使用。
目的:探究艾司西酞普蘭與西酞普蘭治療廣汎性焦慮障礙的臨床效果,為今後的臨床工作提供參攷依據。方法:選取廣汎性焦慮障礙患者120例,按照治療方法的不同分為對照組與觀察組,對照組患者給予西酞普蘭治療,觀察組患者給予艾司西酞普蘭治療,觀察兩組患者治療後的臨床效果及不良反應。結果:治療第2、4、6週末,兩組患者 HAMA 比較差異顯著(P<0.01);治療6週末,艾司西酞普蘭組的總有效率為91.7%,西酞普蘭組的總有效率為80.0%,比較差異有統計學意義(P<0.05)。艾司西酞普蘭組患者的不良反應明顯低于西酞普蘭組(P<0.05),差異有統計學意義。結論:艾司西酞普蘭治療廣汎性焦慮障礙臨床效果良好,不良反應少,值得臨床推廣使用。
목적:탐구애사서태보란여서태보란치료엄범성초필장애적림상효과,위금후적림상공작제공삼고의거。방법:선취엄범성초필장애환자120례,안조치료방법적불동분위대조조여관찰조,대조조환자급여서태보란치료,관찰조환자급여애사서태보란치료,관찰량조환자치료후적림상효과급불량반응。결과:치료제2、4、6주말,량조환자 HAMA 비교차이현저(P<0.01);치료6주말,애사서태보란조적총유효솔위91.7%,서태보란조적총유효솔위80.0%,비교차이유통계학의의(P<0.05)。애사서태보란조환자적불량반응명현저우서태보란조(P<0.05),차이유통계학의의。결론:애사서태보란치료엄범성초필장애림상효과량호,불량반응소,치득림상추엄사용。
Objective:To explore clinical effects of Escitalopram and Citalopram in treatment of generalized anxiety disorder, and provide a reference for future clinical work. Methods:According to different treatment methods, 120 patients with generalized anx-iety disorder were divided into control group and observation group. The cases in control group were treated with Citalopram, while those in observation group were given Escitalopram. The clinical effects and adverse reactions of the two groups were observed after the treatment. Results: There were significant differences in the Hamilton anxiety scale (HAMA) scores at the 2nd, 4th, and 6th week-ends of the treatment between the two groups (P<0. 05). At the 6th weekends of the treatment, the total effective rates of Escitalopram group and Citalopram group were 91. 7% and 80. 0% , respectively; and the difference was significant (P<0. 05). The incidences of the adverse reactions of Escitalopram group were significantly lower than those of Citalopram group, and the difference was statistically significant (P<0. 05). Conclusions: Escitalopram in the treatment of generalized anxiety disorder has good clinical effects, less ad-verse reactions, and is safe and effective. Therefore, it is worthy of promotion.